AR

Anupam Rama

#485 out of 660 analysts
JP Morgan
Automatically Tracked
Tracking: 0 Updated: 24 minutes ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-15.97%
Gain +0.94%
Monthly
-1%
Yearly
-11.4%
Drawdown
86.27%
$38,213.77
Equity
Holdings
$29,635.77
Cash
$8,578
Investment
$34,900.08
-$66,586.36
Profit +$356.34
Realized
-$61,322.05
Unrealized
-$5,264.31
Dividends
$0
$8,578
Cash
Deposits
$104,800.13
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.94%
Profit
$356.34
Win %
23%
This Week
Compared To Last Week
Gain
0.94%
Profit
$356.34
Win %
23%
This Month
Compared to last month
Gain
-12.03%
Profit
-$5,227.1
Win %
32%
This Year
Compared to last year
Gain
-26.83%
Profit
-$14,009.51
Win %
43%
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
+3.57%
+$85.37
Travere Therapeutics Inc. logo
TVTX Travere Therapeutics Inc.
+3.34%
+$83.71
Zai Lab Ltd. logo
ZLAB Zai Lab Ltd.
+3.22%
+$73.36
Solid Biosciences Inc. logo
SLDB Solid Biosciences Inc.
+2.1%
+$48.88
Erasca, Inc. logo
ERAS Erasca, Inc.
+1.62%
+$38.23
Replimune Group Inc. logo
REPL Replimune Group Inc.
+1.52%
-$36.85
First Tracks Biotherapeutics, Inc. logo
TRAX First Tracks Biotherapeutics, Inc.
+1.42%
+$34.54
BridgeBio Pharma, Inc. logo
BBIO BridgeBio Pharma, Inc.
+1.03%
+$24.03
CytomX Therapeutics Inc. logo
CTMX CytomX Therapeutics Inc.
+0.83%
+$19.74
Syndax Pharmaceuticals Inc. logo
SNDX Syndax Pharmaceuticals Inc.
+0.57%
+$13.79
Maze Therapeutics Inc. logo
MAZE Maze Therapeutics Inc.
+0.21%
+$4.88
Apellis Pharmaceuticals Inc. logo
APLS Apellis Pharmaceuticals Inc.
0%
$0
Olema Pharmaceuticals Inc. logo
OLMA Olema Pharmaceuticals Inc.
-0.83%
-$19.69
Neurocrine Biosciences Inc. logo
NBIX Neurocrine Biosciences Inc.
-0.64%
-$14.75
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
1940
Longs Won
843/1832 46%
Profit Factor
0.78
Profitability
Shorts Won
43/108 39%
Standard Deviation
$1,894.91
Average Win
$263.78
Best Trade
(Jul 31) $36,562.63
Sharpe Ratio
-212.39
Average Loss
-$284.91
Worst Trade
(Apr 14) -$44,145.88
Z-Score
-14.2 (100%)
Commissions
$0
Avg. Trade Length
1m 1w 4d
Expectancy
-$34.32
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 134 121 107 94 80 67 54 40 27 13
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV